At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02659 BAO PHARMA-B
Not Yet Opened 04-21 16:08:17
90.500
+0.500
+0.56%
High90.500
Low89.200
Vol292.10K
Open90.050
D1 Closing90.000
Amplitude1.44%
Mkt Cap29.50B
Tradable Cap13.94B
Total Shares325.98M
T/O26.16M
T/O Rate0.19%
Tradable Shares154.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BAO PHARMA-B (02659) Gains Acceptance for Recombinant Ulinastatin (BJ044) IND Application, Pioneering New Era in Recombinant Protein Therapeutics
Shanghai Baoji Pharmaceutical Co., Ltd. focuses on the industrialization and commercialization of recombinant protein drugs and antibody drugs. We have built a cGMP-compliant production site in Shanghai, covering an area of about 63,000 square meters. We have planned multiple production lines covering mammalian cell expression systems and Escherichia coli and yeast expression systems, as well as finished production lines for water injections, freeze-dried powder injections, and disposable pre-encapsulated formulations.